• LAST PRICE
    162.2500
  • TODAY'S CHANGE (%)
    Trending Up4.7200 (2.9963%)
  • Bid / Lots
    162.0900/ 1
  • Ask / Lots
    162.3800/ 1
  • Open / Previous Close
    157.0000 / 157.5300
  • Day Range
    Low 154.4300
    High 163.5500
  • 52 Week Range
    Low 126.9681
    High 225.2300
  • Volume
    183,466
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 157.55
TimeVolumeBGNE
09:32 ET1816154.43
09:34 ET100157.63
09:36 ET100157.29
09:38 ET2210157.28
09:45 ET465158.25
09:48 ET100159.71
09:50 ET100157.96
09:56 ET100157.32
09:57 ET500157.09
10:06 ET1700156.74
10:12 ET100157.745
10:14 ET865157.665
10:15 ET300158.23
10:17 ET100158.45
10:21 ET300158.78
10:30 ET9500159
10:32 ET500159.5
10:33 ET1133159.565
10:35 ET227159.58
10:39 ET11791160.72
10:42 ET810161.175
10:44 ET1782160.985
10:46 ET2253161.605
10:48 ET1072161.5
10:50 ET600161.315
10:53 ET275161.46
10:55 ET500161.66
10:57 ET1078161.48
11:00 ET902161.57
11:02 ET200161.58
11:04 ET200161.32
11:06 ET400161.385
11:09 ET220161.58
11:11 ET800161.6176
11:18 ET1690161.39
11:20 ET100161.41
11:22 ET100161.48
11:26 ET974161.66
11:27 ET224161.65
11:29 ET350161.5424
11:33 ET100161.495
11:36 ET130161.505
11:40 ET100161.65
11:42 ET500161.65
11:44 ET123161.775
11:45 ET200161.78
11:47 ET241161.725
11:49 ET400161.76
11:51 ET522161.955
11:54 ET200161.79
11:56 ET100161.8
12:00 ET100161.725
12:03 ET100161.78
12:05 ET550162
12:07 ET200161.875
12:09 ET794162
12:12 ET800161.92
12:14 ET300161.995
12:16 ET200161.77
12:20 ET200161.76
12:23 ET100161.74
12:25 ET139161.9395
12:27 ET500161.535
12:30 ET700161.86
12:34 ET100161.65
12:36 ET800162.04
12:38 ET300162.64
12:41 ET11235162.82
12:45 ET544163
12:48 ET123162.68
12:50 ET200162.72
12:54 ET416162.65
12:56 ET100162.84
12:57 ET200162.825
01:01 ET100163
01:03 ET200162.86
01:08 ET200162.979
01:10 ET577163
01:12 ET100162.93
01:14 ET1200163.09
01:15 ET100162.93
01:17 ET2900163.265
01:19 ET690163.2
01:21 ET300163.26
01:24 ET326163.06
01:28 ET1507163.22
01:32 ET100163.22
01:33 ET250163.17
01:35 ET1423163.276
01:37 ET1400163.03
01:42 ET100162.91
01:46 ET200163.13
01:48 ET100163.12
01:50 ET100162.89
01:51 ET100163.27
01:53 ET100162.91
01:57 ET200162.85
02:00 ET100162.6
02:02 ET200162.33
02:06 ET100162.43
02:09 ET100162.53
02:11 ET100162.5728
02:13 ET230162.41
02:20 ET420162.17
02:22 ET500162.2
02:24 ET200162.01
02:26 ET500162.15
02:27 ET100162.17
02:29 ET100162.12
02:31 ET300162.08
02:33 ET311162.025
02:36 ET1100162.21
02:38 ET100162.375
02:40 ET400162.4
02:42 ET600162.455
02:44 ET2051162
02:45 ET100162.17
02:47 ET329162.11
02:49 ET200162.285
02:51 ET1202162.11
02:54 ET400161.975
02:56 ET400161.94
02:58 ET200161.94
03:00 ET1060161.54
03:02 ET1000161.275
03:03 ET500161.43
03:05 ET400161.26
03:07 ET500161.6
03:09 ET1383161.92
03:12 ET988162.095
03:14 ET448162.23
03:16 ET207162.48
03:18 ET300162.28
03:20 ET100162.25
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesBGNE
Beigene Ltd
16.9B
-21.4x
---
United StatesBMRN
Biomarin Pharmaceutical Inc
16.0B
79.0x
---
United StatesUTHR
United Therapeutics Corp
14.9B
15.7x
+8.22%
United StatesNBIX
Neurocrine Biosciences Inc
14.6B
40.0x
+62.04%
United StatesEXAS
Exact Sciences Corp
9.1B
-36.2x
---
United StatesMEDP
Medpace Holdings Inc
11.1B
33.6x
+35.10%
As of 2024-07-24

Company Information

BeiGene, Ltd. is a global biotechnology company engaged in discovering and developing oncology treatments for cancer patients worldwide. The Company has discovered and developed three approved medicines, including BRUKINSA, a small molecule inhibitor of Bruton’s Tyrosine Kinase for the treatment of various blood cancers; TEVIMBRA (tislelizumab), an anti-PD-1 antibody immunotherapy for the treatment of various solid tumor and blood cancers; and pamiparib, a selective small molecule inhibitor of poly ADP-ribose polymerase 1 (PARP1) and PARP2. The Company has obtained approvals to market BRUKINSA in the United States, the People's Republic of China (China or the PRC), the European Union, the United Kingdom, Canada, Australia, and additional international markets; tislelizumab in the European Union and China; and pamiparib in China. It also focuses on commercializing cancer medicines, such as XGEVA, BLINCYTO, KYPROLIS, and others in China under an exclusive license from Amgen Inc.

Contact Information

Headquarters
C/O Mourant Governance Services (Cayman) 94 Solaris Avenue, Camana BayGRAND CAYMAN, BEJ, Cayman Islands KY1-1108
Phone
345-949-4123
Fax
---

Executives

Co-Founder, Executive Chairman of the Board, Chief Executive Officer
John Oyler
President, Chief Operating Officer, General Manager - China
Xiaobin Wu
Co-Founder, Non-Executive Director
Xiaodong Wang
Chief Financial Officer
Aaron Rosenberg
Senior Vice President, General Counsel
Chan Lee

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$16.9B
Revenue (TTM)
$2.8B
Shares Outstanding
105.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.59
EPS
$-7.57
Book Value
$36.95
P/E Ratio
-21.4x
Price/Sales (TTM)
6.1
Price/Cash Flow (TTM)
---
Operating Margin
-26.60%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.